Search results
University College London School of Pharmacy - Cited by 2,440 - Pharmaceutics - Pulmonary Drug Delivery
Michael Y.T. Chow's 33 research works with 1,650 citations and 21,161 reads, including: Delivery technology of inhaled therapy for asthma and COPD
Studies investigating RNA therapeutics in pulmonary diseases have rapidly expanded and drug administration by inhalation allows the direct delivery of RNA therapeutics to the target site of action while minimizing systemic exposure.
- Michael Y.T. Chow, Michael Y.T. Chow, Yingshan Qiu, Jenny K.W. Lam
- 2020
Abstract. The clustered regulatory interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (CRISPR/Cas9) system has significant therapeutic potentials for lung congenital diseases such as cystic fibrosis, as well as other pulmonary disorders like lung cancer and obstructive diseases. Local administration of CRISPR/Cas9 ...
- Michael Y.T. Chow, Rachel Yoon Kyung Chang, Hak-Kim Chan
- 2021
Abstract. Inhaled therapy is the cornerstone of the management of asthma and chronic obstructive pulmonary disease (COPD). Drugs such as bronchodilators and corticosteroids are administered directly to the airways for local effect and rapid onset of action while systemic exposure and side effects are minimized.
Michael A. Trick Harry B. and James H. Higgins Professor of Operations Research; Dean, Carnegie Mellon University Qatar. Read full bio
Senior Lecturer, Lee Shau Kee School of Business and Administration. BSc University of Pannonia, MSc Edinburgh Napier University, PhD PolyU. Certification in Hotel Industry Analytics (CHIA), Hotel Real Estate Investments and Asset Management, Certified Hospitality Educator (CHE) HKMU Scholars.
Test your initiative and challenge your perspective at a world-class business school. Learn with a diverse, dynamic group of future leaders in the heart of London.
